Explore

Trendline Trendline
AI Spending Surge Forces Companies to Reevaluate Stock Buyback Strategies

AI Spending Surge Forces Companies to Reevaluate Stock Buyback Strategies

AI Spending Surge Forces Companies to Reevaluate Stock Buyback Strategies
Trendline Trendline
Quantinno Capital Management Increases Stake in Conagra Brands, Impacting Institutional Holdings

Quantinno Capital Management Increases Stake in Conagra Brands, Impacting Institutional Holdings

Quantinno Capital Management Increases Stake in Conagra Brands, Impacting Institutional Holdings
Trendline Trendline
TPG Offers Unique Associate Role in Office of the President with Strategic Insight Opportunities

TPG Offers Unique Associate Role in Office of the President with Strategic Insight Opportunities

TPG Offers Unique Associate Role in Office of the President with Strategic Insight Opportunities
Trendline Trendline
AI Spending Boom Prompts Reevaluation of Stock Buybacks in Tech Sector

AI Spending Boom Prompts Reevaluation of Stock Buybacks in Tech Sector

AI Spending Boom Prompts Reevaluation of Stock Buybacks in Tech Sector
Trendline Trendline
J. M. Smucker Company Receives 'Hold' Rating Amidst Financial Performance Review

J. M. Smucker Company Receives 'Hold' Rating Amidst Financial Performance Review

J. M. Smucker Company Receives 'Hold' Rating Amidst Financial Performance Review
Trendline Trendline
TELUS Reports Q2 2026 Financial Results, Resets Dividend to Support Growth

TELUS Reports Q2 2026 Financial Results, Resets Dividend to Support Growth

TELUS Reports Q2 2026 Financial Results, Resets Dividend to Support Growth
Trendline Trendline
Norwegian Cruise Line Holdings Reports Strong Second Quarter 2026 Financial Results

Norwegian Cruise Line Holdings Reports Strong Second Quarter 2026 Financial Results

Norwegian Cruise Line Holdings Reports Strong Second Quarter 2026 Financial Results
Trendline Trendline
Adidas Faces Profit Challenges Despite World Cup Sales Boost

Adidas Faces Profit Challenges Despite World Cup Sales Boost

Adidas Faces Profit Challenges Despite World Cup Sales Boost
Reuters Reuters
AbbVie trims 2026 profit forecast on Apogee buy, beats second-quarter estimates

AbbVie trims 2026 profit forecast on Apogee buy, beats second-quarter estimates

July 31 (Reuters) - AbbVie trimmed its 2026 profit forecast on Friday to account for its planned Apogee Therapeutics acquisition, while topping second-quarter estimates on strong immunology drug sales. Shares of the drugmaker fell more than 4% in premarket trading.
Reuters Reuters
AbbVie trims 2026 profit view on Apogee deal, tops second-quarter estimates

AbbVie trims 2026 profit view on Apogee deal, tops second-quarter estimates

By Siddhi Mahatole and Puyaan Singh July 31 (Reuters) - AbbVie slightly trimmed its 2026 profit forecast on Friday to account for its planned Apogee Therapeutics acquisition, while topping second-quarter estimates on strong immunology drug sales.
Trendline Trendline
Darling Ingredients Reports Strong Q2 2026 Financial Performance with Revenue Growth

Darling Ingredients Reports Strong Q2 2026 Financial Performance with Revenue Growth

Darling Ingredients Reports Strong Q2 2026 Financial Performance with Revenue Growth
Trendline Trendline
Regeneron Faces Questions Over M Strategy Amid $18 Billion Cash Reserve

Regeneron Faces Questions Over M Strategy Amid $18 Billion Cash Reserve

Regeneron Faces Questions Over M Strategy Amid $18 Billion Cash Reserve